Atlas Trials

A Study to Evaluate the Safety of Fenretinide in Healthy Volunteers

Clinical trial NCT06181760 · COMPLETED

Trial details

NCT number
NCT06181760
Sponsor
Island Pharmaceuticals
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Safety and Tolerability
Start date
2023-11-22
Primary completion
2024-02-13
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.